TY - JOUR AU - Vlassara, H. AU - Bucala, R. AU - Striker, L. PY - 1994 DA - 1994// TI - Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging JO - Lab. Invest. VL - 70 ID - Vlassara1994 ER - TY - JOUR AU - Brownlee, M. PY - 1995 DA - 1995// TI - Advanced protein glycosylation in diabetes and aging JO - Ann. Rev. Med. VL - 46 UR - https://doi.org/10.1146/annurev.med.46.1.223 DO - 10.1146/annurev.med.46.1.223 ID - Brownlee1995 ER - TY - JOUR AU - Dyer, D. G. AU - Blackledge, J. A. AU - Thorpe, S. R. AU - Baynes, J. W. PY - 1991 DA - 1991// TI - Formation of pentosidine during nonenzymatic browning of proteins by glucose JO - J. Biol. Chem. VL - 18 ID - Dyer1991 ER - TY - JOUR AU - Grandhee, S. AU - Monnier, V. M. PY - 1991 DA - 1991// TI - Mechanism of formation of the Maillard protein cross-link pentosidine JO - J. Biol. Chem. VL - 18 ID - Grandhee1991 ER - TY - JOUR AU - Schmidt, A. M. AU - Stern, D. PY - 2000 DA - 2000// TI - Atherosclerosis and diabetes: the RAGE connection JO - Curr Atheroscler Rep. VL - 5 UR - https://doi.org/10.1007/s11883-000-0082-4 DO - 10.1007/s11883-000-0082-4 ID - Schmidt2000 ER - TY - JOUR AU - Schmidt, A. M. AU - Yan, S. D. AU - Wautier, J. L. AU - Stern, D. PY - 1999 DA - 1999// TI - Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis JO - Circ. Res. VL - 84 UR - https://doi.org/10.1161/01.RES.84.5.489 DO - 10.1161/01.RES.84.5.489 ID - Schmidt1999 ER - TY - JOUR AU - Yamagishi, S. AU - Imaizumi, T. PY - 2005 DA - 2005// TI - Diabetic vascular complications: pathophysiology, biochemical basis and potential therapeutic strategy JO - Curr. Pharm. Des. VL - 11 UR - https://doi.org/10.2174/1381612054367300 DO - 10.2174/1381612054367300 ID - Yamagishi2005 ER - TY - JOUR AU - Ueda, S. PY - 2006 DA - 2006// TI - Oral adsorbent AST-120 decreases serum levels of AGEs in patients with chronic renal failure JO - Mol. Med. VL - 180 ID - Ueda2006 ER - TY - JOUR AU - Park, L. PY - 1998 DA - 1998// TI - Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end products JO - Nat. Med. VL - 4 UR - https://doi.org/10.1038/2012 DO - 10.1038/2012 ID - Park1998 ER - TY - JOUR AU - Bucciarelli, L. PY - 2002 DA - 2002// TI - RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice JO - Circulation VL - 106 UR - https://doi.org/10.1161/01.CIR.0000039325.03698.36 DO - 10.1161/01.CIR.0000039325.03698.36 ID - Bucciarelli2002 ER - TY - STD TI - Nakamura K et al. (2006) Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease. Diabetes Metab. Res. Rev. 10.1002/dmrr.690 ID - ref11 ER - TY - JOUR PY - 1997 DA - 1997// TI - Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus JO - Diabetes Care VL - 20 UR - https://doi.org/10.2337/diacare.20.7.1183 DO - 10.2337/diacare.20.7.1183 ID - ref12 ER - TY - JOUR AU - Ferri, C. AU - Desideri, G. AU - Baldoncini, R. AU - Bellini, C. AU - Angelis, C. AU - Mazzocchi, C. AU - Santucci, A. PY - 1998 DA - 1998// TI - Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities JO - Diabetes VL - 47 UR - https://doi.org/10.2337/diabetes.47.4.660 DO - 10.2337/diabetes.47.4.660 ID - Ferri1998 ER - TY - JOUR AU - Rosei, E. n. r. i. c. o. A. g. a. b. i. t. i. AU - Rizzoni, D. a. m. i. a. n. o. AU - Muiesan, M. a. r. i. a. L. o. r. e. n. z. a. AU - Sleiman, I. n. t. i. s. s. a. r. AU - Salvetti, M. a. s. s. i. m. o. AU - Monteduro, C. r. i. s. t. i. n. a. AU - Porteri, E. n. z. o. PY - 2005 DA - 2005// TI - Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus JO - Journal of Hypertension VL - 23 UR - https://doi.org/10.1097/00004872-200502000-00027 DO - 10.1097/00004872-200502000-00027 ID - Rosei2005 ER - TY - JOUR AU - Steiner, M. AU - Reinhardt, K. M. AU - Krammer, B. AU - Ernst, B. AU - Blann, A. D. PY - 1994 DA - 1994// TI - Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control JO - Thromb. Haemost. VL - 72 UR - https://doi.org/10.1055/s-0038-1648993 DO - 10.1055/s-0038-1648993 ID - Steiner1994 ER - TY - JOUR AU - Nakamura, K. PY - 2005 DA - 2005// TI - Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension JO - Microvasc. Res. VL - 70 UR - https://doi.org/10.1016/j.mvr.2005.10.002 DO - 10.1016/j.mvr.2005.10.002 ID - Nakamura2005 ER - TY - JOUR AU - Yamagishi, S. PY - 2006 DA - 2006// TI - Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects JO - Metabolism VL - 55 UR - https://doi.org/10.1016/j.metabol.2006.05.007 DO - 10.1016/j.metabol.2006.05.007 ID - Yamagishi2006 ER - TY - JOUR AU - Pachydaki, S. I. PY - 2006 DA - 2006// TI - Upregulation of RAGE and its ligands in proliferative retinal disease JO - Exp. Eye Res. VL - 82 UR - https://doi.org/10.1016/j.exer.2005.09.022 DO - 10.1016/j.exer.2005.09.022 ID - Pachydaki2006 ER - TY - JOUR AU - Cipollone, F. PY - 2003 DA - 2003// TI - The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control JO - Circulation VL - 108 UR - https://doi.org/10.1161/01.CIR.0000086014.80477.0D DO - 10.1161/01.CIR.0000086014.80477.0D ID - Cipollone2003 ER - TY - JOUR AU - Tanji, N. PY - 2000 DA - 2000// TI - Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease JO - J. Am. Soc. Nephrol. VL - 11 ID - Tanji2000 ER - TY - JOUR AU - Schlueter, C. AU - Hanke, S. AU - Flohr, A. M. AU - Rogalla, P. AU - Bullerdiek, J. PY - 2003 DA - 2003// TI - Tissue specific expression patterns of RAGE receptor and its soluble forms: a result of regulated alternative splicing? JO - Biochem. Biophys. Acta VL - 1630 ID - Schlueter2003 ER - TY - JOUR AU - Hudson, B. I. AU - Harja, E. AU - Moser, B. AU - Schmidt, A. M. PY - 2005 DA - 2005// TI - Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein? JO - Arterioscler. Thromb. Vasc. Biol. VL - 25 UR - https://doi.org/10.1161/01.ATV.0000164804.05324.8b DO - 10.1161/01.ATV.0000164804.05324.8b ID - Hudson2005 ER - TY - JOUR AU - Gu, L. PY - 2006 DA - 2006// TI - Role of receptor for advanced glycation end-products and signaling events in advanced glycation end-product-induced monocyte chemoattractant protein-1 expression in differentiated mouse podocytes JO - Nephrol. Dial. Transplant. VL - 21 UR - https://doi.org/10.1093/ndt/gfi210 DO - 10.1093/ndt/gfi210 ID - Gu2006 ER - TY - JOUR AU - Inagaki, Y. AU - Yamagishi, S. AU - Okamoto, T. AU - Takeuchi, M. AU - Amano, S. PY - 2003 DA - 2003// TI - Pigment epithelium-derived factor prevents advanced glycation end products-induced monocyte chemoattractant protein-1 production in microvascular endothelial cells by suppressing intracellular reactive oxygen species generation JO - Diabetologia VL - 46 UR - https://doi.org/10.1007/s00125-002-1013-4 DO - 10.1007/s00125-002-1013-4 ID - Inagaki2003 ER - TY - JOUR AU - Rashid, G. AU - Benchetrit, S. AU - Fishman, D. AU - Bernheim, J. PY - 2004 DA - 2004// TI - Effect of advanced glycation end-products on gene expression and synthesis of TNF-alpha and endothelial nitric oxide synthase by endothelial cells JO - Kidney Int. VL - 66 UR - https://doi.org/10.1111/j.1523-1755.2004.00860.x DO - 10.1111/j.1523-1755.2004.00860.x ID - Rashid2004 ER - TY - JOUR AU - Cataldegirmen, G. PY - 2005 DA - 2005// TI - RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB JO - J. Exp. Med. VL - 201 UR - https://doi.org/10.1084/jem.20040934 DO - 10.1084/jem.20040934 ID - Cataldegirmen2005 ER - TY - JOUR AU - Galli, F. AU - Benedetti, S. AU - Floridi, A. AU - Canestrari, F. AU - Piroddi, M. AU - Buoncristiani, E. AU - Buoncristiani, U. PY - 2005 DA - 2005// TI - Glycoxidation and inflammatory markers in patients on treatment with PMMA-based protein-leaking dialyzers JO - Kidney Int. VL - 67 UR - https://doi.org/10.1111/j.1523-1755.2005.67138.x DO - 10.1111/j.1523-1755.2005.67138.x ID - Galli2005 ER - TY - JOUR AU - Hein, G. E. AU - Kohler, M. AU - Oelzner, P. AU - Stein, G. AU - Franke, S. PY - 2005 DA - 2005// TI - The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis JO - Rheumatol. Int. VL - 26 UR - https://doi.org/10.1007/s00296-004-0518-1 DO - 10.1007/s00296-004-0518-1 ID - Hein2005 ER - TY - JOUR AU - Schindhelm, R. K. PY - 2006 DA - 2006// TI - Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease JO - Diabetes Metab. Res. Rev. VL - 22 UR - https://doi.org/10.1002/dmrr.666 DO - 10.1002/dmrr.666 ID - Schindhelm2006 ER - TY - JOUR AU - Tan PY - 2006 DA - 2006// TI - Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes JO - Diabetologia VL - 49 UR - https://doi.org/10.1007/s00125-006-0394-1 DO - 10.1007/s00125-006-0394-1 ID - Tan2006 ER - TY - JOUR AU - Geroldi, D. AU - Falcone, C. AU - Emanuele, E. PY - 2006 DA - 2006// TI - Soluble receptor for advanced glycation end products: from disease marker to potential therapeutic target JO - Curr. Med. Chem. VL - 13 UR - https://doi.org/10.2174/092986706777585013 DO - 10.2174/092986706777585013 ID - Geroldi2006 ER - TY - JOUR AU - Basta, G. PY - 2006 DA - 2006// TI - Circulating soluble receptor for advanced glycation end products is inversely associated with glycemic control and S100A12 protein JO - J. Clin. Endocrinol. Metab. VL - 91 UR - https://doi.org/10.1210/jc.2005-2559 DO - 10.1210/jc.2005-2559 ID - Basta2006 ER - TY - JOUR AU - Katakami, N. PY - 2005 DA - 2005// TI - Decreased endogenous secretory advanced glycation end product receptor in type 1 diabetic patients: its possible association with diabetic vascular complications JO - Diabetes Care VL - 28 UR - https://doi.org/10.2337/diacare.28.11.2716 DO - 10.2337/diacare.28.11.2716 ID - Katakami2005 ER - TY - JOUR AU - Koyama, H. PY - 2005 DA - 2005// TI - Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis JO - Arterioscler. Thromb. Vasc. Biol. VL - 25 UR - https://doi.org/10.1161/01.ATV.0000190660.32863.cd DO - 10.1161/01.ATV.0000190660.32863.cd ID - Koyama2005 ER - TY - JOUR AU - Yonekura, H. PY - 2003 DA - 2003// TI - Novel splice variants of the receptor for advanced glycation endproducts expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury JO - Biochem. J. VL - 370 UR - https://doi.org/10.1042/bj20021371 DO - 10.1042/bj20021371 ID - Yonekura2003 ER -